-
Sector Analysis
NewFeminine Hygiene Market Opportunities, Trends, Growth Analysis and Forecast to 2028
Feminine Hygiene Market Report Overview The feminine hygiene market size was $37.5 billion. The market will grow at a CAGR of more than 4% during 2023-2028. The following are some of the key highlights of the feminine hygiene market: The potential long-term effects of exposing intimate areas to synthetic and potentially harmful chemicals are compelling women to seek safer alternatives. Asia-Pacific represented the largest feminine hygiene market regional share in 2023. Among all regions, private labels held their highest collective value...
-
Sector Analysis
NewHousehold Products Market Opportunities, Trends, Growth Analysis and Forecast to 2028
Household Products Market Report Overview The household products market size was valued at $314 billion in 2023. Growing consumer concerns about health and hygiene are creating a surge in demand for anti-bacterial, plant-based, and natural household products. Moreover, rising environmental concerns among consumers are stimulating the adoption of sustainable and eco-friendly household products. These factors are expected to drive the household products market growth at a CAGR of more than 4% from 2023 to 2028. Household Products Market Outlook 2023-2028...
-
Consumer Insights
NewFood Packaging Industry Trends, Opportunities, Growth Analysis and Forecast to 2028
Food Packaging Industry Report Overview The food packaging volume was 2 trillion units in 2023 and will grow at a CAGR of more than 1% during 2023-2028. Technology, regulations, and convenience are key factors influencing the food packaging market, while sustainability, functionality, and customer engagement are key focus areas. Food Packaging Industry Outlook, 2023-2028 (Trillion Units) Buy the Full Report for More Insights into the Food Packaging Industry Forecast Download a Free Report Sample The food packaging industry report provides...
-
Product Insights
Santo Agostinho 27
Santo Agostinho 27 is an Onshore Wind project located in Rio Grande do Norte, Brazil. The project is owned by Engie SA and others and is developed by Eolica Santo Agostinho 27 Ltda. The project is currently under construction. Empower your strategies with our Santo Agostinho 27 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Consumer Insights
NewMorocco Baby Food Market Size and Share by Categories, Distribution and Forecast to 2029
Morocco Baby Food Market Report Overview The baby food sales in Morocco were worth MAD1.1 billion in 2023. The Morocco baby food market will record a CAGR of more than 1% during 2023-2029. The Morocco baby food market outlook includes demographic and socio-economic trends to aid clients in effective decision-making. Morocco Baby Food Market Outlook, 2023-2029 (MAD Billion) Buy the Full Report for More Insights on the Morocco Baby Food Market Forecast Download a Free Report Sample The Morocco baby food...
-
Sector Analysis
NewSkincare Market Opportunities, Trends, Growth Analysis and Forecast to 2028
Skincare Market Report Overview The skincare market size was valued at $163.5 billion in 2023. Consumers’ increasing concerns about skin nourishment and rising preferences for a healthy skincare regime are strengthening the demand for skincare products, especially facial and body care solutions. These factors are expected to drive the skincare market growth at a CAGR of more than 2% from 2023 to 2028. Skincare Market Outlook 2023-2028 (USD Billion) Buy the Full Report for More Insights on the Skincare Market...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pembrolizumab Biosimilar in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pembrolizumab Biosimilar in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pembrolizumab Biosimilar in Non-Small Cell Lung Cancer Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Casdozokitug in Metastatic Hepatocellular Carcinoma (HCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Casdozokitug in Metastatic Hepatocellular Carcinoma (HCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Casdozokitug in Metastatic Hepatocellular Carcinoma (HCC) Drug Details: Casdozokitug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Casdozokitug in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Casdozokitug in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Casdozokitug in Non-Small Cell Lung Cancer Drug Details: Casdozokitug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Casdozokitug in Squamous Non-Small Cell Lung Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Casdozokitug in Squamous Non-Small Cell Lung Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Casdozokitug in Squamous Non-Small Cell Lung Carcinoma Drug...